$MRK Merck & Co Q3 Earnings
Adj. EPS $2.49, est. $2.07
Rev. $18.09B, est. $17.31B
Keytruda rev. $8.60B, est. $8.38B
Gardasil rev. $2.00B, est. $1.75B
Keytruda Qlex rev. $830M, est. $699.6M
Winrevair rev. $694M, est. $643.1M
Animal Health sales $1.68B, est. $1.69B
Sees FY sales $66.8B to $67.3B, saw $66.3B to $67.3B
Sees FY Adj. EPS $2.77 to $2.82, saw $2.66 to $2.76
Still sees FY Adj. gross margin about 81%, est. 81%